The Arizona Health Care Cost Containment System (AHCCCS), in partnership with Crisis Response Network, announces a new COVID-19 appointment and transportation navigation program for Medicaid members. Now, Medicaid members who need assistance scheduling a COVID-19 vaccine appointment, as well as transportation to and from that appointment, can call 1-844-542-8201, 8 a.m. to 5 p.m., seven days a week.Continue reading
Category Archives: COVID-19 News and Info
COVID-19 Testing Comes to Arizona’s Schools
Arizona’s leading diagnostic testing lab, Sonora Quest Laboratories, is teaming up with Ginkgo Bioworks, Inc. (“Ginkgo”), the organism company, a Boston-based biotechnology firm committed to supporting the fight against COVID-19, to provide pooled COVID-19 testing to K-12 school districts throughout Arizona. Continue reading
Indoor Drive-Thru Vaccination Site Opens at Dexcom in Mesa
“At Dexcom, our mission is to help improve the health of others, so when asked if we could provide our facility for an indoor mass-vaccination site, we didn’t hesitate,” said Jim Kasselmann, senior director of manufacturing in Mesa for Dexcom. “We are proud to manufacture our products in Mesa, and anytime we can help our local community, that is what we will do.”Continue reading
AZBio Health Innovation Spotlight Public Information Campaign Kicks Off with Vaccine Information
The Sonoran Living Health Innovation Spotlight Public Information Campaign is designed to tackle one of our bioscience industry’s greatest challenges, the “Who Knew” Effect.
Arizona life science innovators are working to discover, develop, and deliver life saving and life changing innovations.
In 2021, AZBio is pleased to partner with ABC15 and CW61 to share quick Sonoran Living Health Innovation Spotlights during the morning and evening news hours along with longer segments on Sonoran Living periodically during 2021 to help our community learn more about the work of Arizona’s healthcare innovators. Each segment touches on a public health challenge or opportunity and spotlights an Arizona life science company’s work to create a solution.
Investigational AstraZeneca vaccine prevents COVID-19
Results from a large clinical trial in the United States and South America indicate that AstraZeneca’s COVID-19 vaccine, AZD1222, is well-tolerated and protects against symptomatic COVID-19 disease, including severe disease or hospitalization. The independent Data and Safety Monitoring Board (DSMB) overseeing the trial identified no safety concerns related to the vaccine. The United Kingdom-based global biopharmaceutical company AstraZeneca developed the vaccine and led the trial as regulatory sponsor.Continue reading
Novel Coronavirus Circulated Undetected Months Before First COVID-19 Cases in Wuhan
A new study dates emergence of the virus that causes COVID-19 to as early as October 2019. Simulations also suggest that in most cases, zoonotic viruses die out naturally before causing a pandemic.Continue reading
NIH starting enrollment for third trial of blood clotting treatments for COVID-19
The National Institutes of Health has launched the last of three Phase 3 clinical trials to evaluate the safety and effectiveness of blood thinners to prevent life-threatening blood clots in adults diagnosed with COVID-19. The first patient in the trial was enrolled on February 15.
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
-
Action Advances Fight Against COVID-19, Follows Comprehensive Evaluation of Available Safety, Effectiveness and Manufacturing Quality Information by FDA Career Scientists, Input from External Experts
eNAMPT, the Inflammation-Regulatory Protein Specifically Targeted by Aqualung Therapeutic’s Monoclonal Antibody ALT-100, is now Tightly Linked to Outcomes in COVID-19 Infected Patients
TUCSON, AZ / ACCESSWIRE / February 11, 2021 / Several recent publications have now highlighted the involvement of extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in the pathobiology of SARS-CoV-2 infection.
Free Resource for Businesses – Pandemic Response, Recovery and Planning
This handbook for businesses on pandemic response lessons learned with some considerations businesses can look at on re-opening, vaccine hesitancy, preparing for the next pandemic now, etc. was developed by the Northeast Business Group on Health. Continue reading